Related Experiment Video
Updated: May 23, 2025

Subculture and Cryopreservation of Esophageal Adenocarcinoma Organoids: Pros and Cons for Single Cell Digestion
Published on: July 6, 2022
Cell-based immunotherapy in oesophageal cancer
Masoud Lahouty1, Amirhossein Soleymanzadeh2, Sama Kazemi2
1Pediatric Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Cell therapy offers new hope for oesophageal cancer (EC) patients, showing promise beyond traditional treatments. This approach, including stem cell and non-stem cell options, is being explored for improved survival and safety in oesophageal squamous cell carcinoma (ESCC).
Area of Science:
- Oncology
- Regenerative Medicine
- Cancer Therapeutics
Background:
- Oesophageal cancer (EC) has a poor prognosis, with high rates of recurrence and metastasis despite conventional treatments like surgery, radiotherapy, and chemotherapy.
- There is a critical need for innovative and effective therapeutic strategies to improve outcomes for EC patients, particularly those with oesophageal squamous cell carcinoma (ESCC).
Purpose of the Study:
- To review the theoretical underpinnings and recent progress in cell therapy for oesophageal cancer.
- To examine current clinical trials and summarize survival and safety data for cell-based treatments in EC.
Main Methods:
- Review of existing literature on cell therapy approaches for oesophageal cancer.
- Analysis of data from ongoing and completed clinical studies involving cell-based treatments.
- Assessment of survival rates and safety profiles reported in relevant studies.
Main Results:
- Cell therapy, encompassing both stem cell and non-stem cell interventions, is emerging as a promising innovative treatment for EC.
- Preliminary data from clinical studies suggest potential benefits in survival and acceptable safety profiles for cell-based therapies in ESCC patients.
Conclusions:
- Cell therapy represents a significant advancement in the treatment landscape for oesophageal cancer, offering a novel therapeutic avenue.
- Further clinical investigation is warranted to fully establish the efficacy and long-term safety of cell-based treatments for EC and ESCC.
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

